Precision Medicine 

 

Precision Medicine, Wednesday 4 December 2019

08:00

Registration & Refreshments

09:30

Audience Q&A

John Castle
09:40

Big Data & Machine Learning for Neoantigens, Vaccines and TCRs

10:00

Audience Q&A

Dr Carl Barrett
10:10

Accelerating Drug Development Using CtDNA

10:30

Speed Networking

11:00

Morning Refreshments

round tables
11:40

Roundtables

"Tissunomics" - how to integrate clinical and molecular data in tissue diagnostics
Santiago Ramon Y Cajal

Santiago Ramon Y Cajal, Chairman Of Pathology Department, Vall Dhebron Barcelona Hospital Campus

Commercial Diagnostic strategy in a changing diagnostic landscape
Jens Klabunde

Jens Klabunde, Diagnostics Strategy Leader, Personalized Healthcare, Roche

Epigenetics: drivers or passengers in transcription regulation and disease etiology
Rabih Murr

Rabih Murr, Group Leader, University of Geneva

How to integrate liquid biopsies into routine care
Alexandre Harle

Alexandre Harle, Assistant Professor, Institut de Cancérologie de Lorraine

Integrating Genomics into routine clinical trials
Sandra Mitrovic

Sandra Mitrovic, University Hospital of Basel

12:30

Networking Lunch

14:35

Networking Break

16:10

Afternoon Networking Break

last published: 20/Nov/19 11:45

Precision Medicine, Thursday 5 December 2019

Emmanuelle Di Tomaso
09:00

Developing Biomarkers for an NTRK Inhibitor in a tissue agnostic indication

Bruno Gomes
10:40

Challenges and Opportunities for Biomarkers in Early Clinical Development

11:00

Morning Refreshments

round tables
11:40

Roundtables

Best practice for analytical techniques to improve precision medicine
Markus Paulmichl

Markus Paulmichl, Chair Of Department Of Personalised Medicine, Humanomed

Computational drug repurposing in the time of ML/AI - where are we now?
Charles Roberts

Charles Roberts, Co Founder And Chief Partnership Officer, Freenome

Current technologies and future challenges in single cell research
Emilio Yanguez

Emilio Yanguez, Ngs Scientist, Functional Genomics Center

From targeting tumor mutations to finding cancer predisposition genes: the other side of the coin
How can academics and industry work together to turn basic science into better patient outcomes
Christopher Peters

Christopher Peters, Clinical Senior Lecturer And Consultant Upper Gi And General Surgeon, Imperial College London

How can we obtain the maximum information from liquid biopsies and translate it to the clinic?
Lorena Dieguez

Lorena Dieguez, Group Head, Nano4Health Unit, International Iberian nanotechnology laboratory

Overcoming the challenges of implementing genomics in healthcare
Rolf Apweiler

Rolf Apweiler, Embl-Ebi Director, EMBL- EBI

Single Cell Analysis---Clinical purposes and methods: from dissociation to comprehensive analysis of single cells
Tumor evolution and clinical trajectories of prostate cancer. Targeting the root of the disease
12:30

Networking Lunch

Precision Medicine

Precision Medicine

Jan Christoph Brase
Precision Medicine
13:35

Precision Medicine in Melanoma

Jean-Claude Marshall
Precision Medicine
13:55

Precision Medicine in Pfizer’s Early Clinical Portfolio

Shai Shen-Orr
Precision Medicine
14:15

Presentation by CytoReason

14:35

Afternoon Refreshments

Eike Staub
Precision Medicine
15:40

Development of a Digital X-Omics Platform for ClinicalN Research on Big Biomarker Data

Dr Philip Beer
Precision Medicine
16:00

Transitioning complex cancer genomics into routine oncology practice

16:20

Afternoon Refreshments

Charles Cox
Precision Medicine
17:05

Two decades of pharmacogenetics research at GSK: patient impacts and future directions

Precision Medicine
17:25

Sponsor Presentation

Michael Fraser
Precision Medicine
17:45

The Many Genomes of Prostate Cancer

Close of Conference

last published: 20/Nov/19 11:45

 

Contact us

To sponsor or exhibit contact:
Harry Ludbrook
+44 (0)207 092 1049

Harry.Ludbrook@terrapinn.com


To speak:
Diana Georgi
+44 (0)20 7092 1075

Diana.georgi@terrapinn.com